FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies

Shi Hu
    Product form
      FORMAT: Hardback
      YOU COULD EARN 0 FUTURE RETAIL DISCOUNTS.

      This product is either out of print or out of stock. Add it to your wishlist and we will automatically let you know if it comes back into stock. Add to Wishlist

      ESTIMATED DELIVERY: Possibly out of print
      BUY NOW PAY LATER
      From R 0.00 per month!
      3x monthly payments of R 0.00 with
      4x fortnightly payments of R 0.00 with

      This product is either out of print or out of stock. Add it to your wishlist and we will automatically let you know if it comes back into stock. Add to Wishlist

      Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents a description of the sensitizers used to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs and other sensitizers. The book gives insights into the landscape of anti-EGFR based cancer treatments, the challenges of targeted therapy, and a glimpse into the future of antibody therapy. It offers pertinent science information on strategies used for the rational design and discovery of novel sensitizing agents, and in addition, translational studies involving pre-clinical and clinical design. This book is an indispensable resource for cancer researchers, medicinal chemists and other biomedical scientists.Finally, the book covers basic science strategies used in drug discovery and preclinical evaluation focused on EGFR blockage resistance, as well as clinical trial methodology, including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new anticancer sensitizers for anti-EGFR drug resistance.
      Format: CONTRIBUTORS: Shi Hu EAN: 9780128215845 COUNTRY: United States PAGES: WEIGHT: 680 g HEIGHT: 235 cm
      PUBLISHED BY: Elsevier Science Publishing Co Inc DATE PUBLISHED: 2022-11-17 CITY: GENRE: SCIENCE / Life Sciences / Biology, SCIENCE / Life Sciences / General WIDTH: 191 cm SPINE:

      Book Themes:

      Oncology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Dr. Shi Hu received an MD and a PhD in tumor immunology from Second Military Medical University, Shanghai, China. Since 2015, Dr. Hu leads a research laboratory in the Department of Biophysics, at second military medical university with a faculty position. His laboratory is interested in synthetic immunology based cancer therapeutics and antibody engineering, primarily development of novel sensitizers for antibody-based therapies (e.g., Anti-ERBB antibodies). Dr. Hu’s research is currently supported by the National Natural Science Foundation of China.
      Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents a description of the sensitizers used to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs and other sensitizers. The book gives insights into the landscape of anti-EGFR based cancer treatments, the challenges of targeted therapy, and a glimpse into the future of antibody therapy. It offers pertinent science information on strategies used for the rational design and discovery of novel sensitizing agents, and in addition, translational studies involving pre-clinical and clinical design. This book is an indispensable resource for cancer researchers, medicinal chemists and other biomedical scientists.Finally, the book covers basic science strategies used in drug discovery and preclinical evaluation focused on EGFR blockage resistance, as well as clinical trial methodology, including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new anticancer sensitizers for anti-EGFR drug resistance.
      Format: CONTRIBUTORS: Shi Hu EAN: 9780128215845 COUNTRY: United States PAGES: WEIGHT: 680 g HEIGHT: 235 cm
      PUBLISHED BY: Elsevier Science Publishing Co Inc DATE PUBLISHED: 2022-11-17 CITY: GENRE: SCIENCE / Life Sciences / Biology, SCIENCE / Life Sciences / General WIDTH: 191 cm SPINE:

      Book Themes:

      Oncology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Dr. Shi Hu received an MD and a PhD in tumor immunology from Second Military Medical University, Shanghai, China. Since 2015, Dr. Hu leads a research laboratory in the Department of Biophysics, at second military medical university with a faculty position. His laboratory is interested in synthetic immunology based cancer therapeutics and antibody engineering, primarily development of novel sensitizers for antibody-based therapies (e.g., Anti-ERBB antibodies). Dr. Hu’s research is currently supported by the National Natural Science Foundation of China.

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account